+12 Advanced Cell Technology Ideas. Surgeons in london have transplanted stem cells into a human eye as part of a clinical trial for a new method to. Lasts long with a slow degeneration rate;
Astellas institute for regenerative medicine is a subsidiary of astellas pharma located in marlborough, massachusetts, us, developing stem cell therapies with a focus on diseases that cause blindness. In february 2016 ocata was acquired by astellas for $379 million usd. This was particularly true in may 2005,.
